Propanc Biopharma, Inc. (PPCB) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2022 | $4.1K | +80.4% |
| 2021 | $2.3K | -96.6% |
| 2020 | $67.0K | — |
| 2014 | $87.8K | — |
| 2013 | $0 | -100.0% |
| 2012 | $179 | +35.6% |
| 2011 | $132 | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2022 | $4.1K | +80.4% |
| 2021 | $2.3K | -96.6% |
| 2020 | $67.0K | — |
| 2014 | $87.8K | — |
| 2013 | $0 | -100.0% |
| 2012 | $179 | +35.6% |
| 2011 | $132 | — |